• OCTOBER 29, 1999

Bombay Dyeing considers hiving off DMT division

Bombay Dyeing has initiated a feasibility study for hiving off its loss making di-methyl terephthalate (DMT) division. The division has been incurring losses for some years now and has been primarily responsible for the company's subdued performance over the years.

The company is evaluating the options of either getting out of the business or roping in an ally for the new company that will formed to take over the DMT business. Bombay Dyeing plans to focus on its textiles business.

The hive off will benefit the company in two ways. First, it will no longer have to support a loss making division. This will improve overall profitability. Second, the sale will result in fresh cash inflow into the company. This could be used to beef up its marketing network. Moreover, the company can then step up its advertisement budget to reinforce its brand image. This will help it in achieving leadership status in the textiles sector.

The only drawback of the sale would be that the company would have to source its raw materials from the market. This could put pressure on margins in times of higher DMT prices.

Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

Equitymaster Agora Research Private Limited (Research Analyst)
103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407